Investors have until November 10, 2026, to seek lead plaintiff status in a class action lawsuit challenging the $9.15 per share cash merger of Dun & Bradstreet Holdings, Inc. completed in August 2025.
A Rosen Law Firm notice reminds investors of the November 10, 2026 lead plaintiff deadline in a securities fraud class action over the $9.15 per share Clearlake merger completed August 26, 2025. Because the merger took the company private and the shares ceased trading, the lawsuit notice has no effect on a market price for the stock.
Rosen Law Firm has issued a reminder regarding the November 10, 2026, lead plaintiff deadline for a securities class action against Dun & Bradstreet Holdings, Inc. The lawsuit alleges that the company's proxy statement for its August 26, 2025, merger with Clearlake Capital Group, L.P. contained misleading information regarding the firm's value and undisclosed conflicts of interest involving Executive Chairman Foley.
No. The article describes a merger completed on August 26, 2025 at $9.15 per share in cash, after which the shares no longer trade, so the class action notice has no market price impact.
It alleges the merger proxy misled investors about the true value of the company and the sale process, including omissions about Executive Chairman Foley's personal interest in a quick sale and Bank of America Securities' valuations of superior alternatives.